Gossamer Bio, Inc. (GOSS)
2.89
+0.15
(+5.47%)
USD |
NASDAQ |
Jan 22, 13:48
Gossamer Bio Free Cash Flow: -158.51M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals, Inc. | -164.63M |
| XOMA Royalty Corp. | -15.89M |
| Rezolute, Inc. | -70.49M |
| Axsome Therapeutics, Inc. | -101.39M |
| Crinetics Pharmaceuticals, Inc. | -356.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -36.17M |
| Cash from Investing (Quarterly) | 17.01M |
| Cash from Financing (Quarterly) | 1.872M |
| Free Cash Flow Per Share (Quarterly) | -0.1586 |
| Free Cash Flow to Equity (Quarterly) | -36.21M |
| Free Cash Flow to Firm (Quarterly) | -33.42M |
| Free Cash Flow Yield | -24.14% |